Preferred Label : Bevacizumab/Cisplatin/Pemetrexed Regimen;
NCIt synonyms : Bevacizumab-Cisplatin-Pemetrexed; Bevacizumab-Cisplatin-Pemetrexed Regimen; Avastin/Cisplatin/Pemetrexed; Bevacizumab/Cisplatin/Pemetrexed;
NCIt related terms : Cisplatin, Pemetrexed, Bevacizumab; Cisplatin, Pemetrexed, Bevacizumab-bvzr; Cisplatin, Pemetrexed, Bevacizumab-equi; Cisplatin, Pemetrexed, Bevacizumab-maly; Cisplatin, Pemetrexed, Bevacizumab-aybi; Cisplatin, Pemetrexed, Bevacizumab-onbe; Cisplatin, Pemetrexed, Bevacizumab-awwb; Cisplatin, Pemetrexed, Bevacizumab-adcd;
NCIt definition : A regimen consisting of bevacizumab, cisplatin and pemetrexed that is used for the
treatment of non-small cell lung cancer (NSCLC).;
NCI Metathesaurus CUI : CL523593;
Codes from synonyms : 26085; 127488; 127414; 127636; 127340; 127562; 127266; 127192;
Origin ID : C136282;
UMLS CUI : C4528689;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
- regimen_has_accepted_use_for_disease
